Emerging approaches in preventing cardiovascular disease
- 15 May 1999
- Vol. 318 (7194) , 1337-1341
- https://doi.org/10.1136/bmj.318.7194.1337
Abstract
This is the first of four articles Reducing cholesterol and blood pressure, as well as smoking cessation, have been shown to be effective strategies for preventing cardiovascular diseases.1 However, these “classical” risk factors, along with known non-modifiable risk factors such as age, sex, and family history, cannot fully explain why some people develop myocardial infarction and stroke, while others do not.2–4 Additional factors may have a role in the pathogenesis of atherosclerosis, and new preventive strategies may be of use. In this article we briefly review the use of antioxidants, the use of angiotensin converting enzyme inhibitors, and homocysteine lowering; other “emerging” cardiovascular risk factors and potential preventive strategies that are under investigation are summarised in table 1. ### Summary points Classical risk factors for atherosclerosis cannot fully explain why certain people develop coronary heart disease and stroke, while others do not Other potential (“emerging”) risk factors for atherosclerosis and new preventive therapies are currently being studied Promising new preventive therapies include antioxidants, lowering of homocysteine concentrations, decreasing the activation of the renin-angiotensin and the coagulation systems, antibiotics, and anti-inflammatory agents These therapies have not been proved in clinical trials; at present, the emphasis should be on treating established risk factors and consistently applying therapies that are known to reduce cardiovascular morbidity and mortality Extensive laboratory data show that oxidative modification of low density lipoprotein cholesterol is an important step in the pathogenesis of atherosclerosis, and experimental studies in different animal models show that antioxidants decrease oxidation of low density lipoprotein cholesterol and reduce plaque formation. 5 6 Epidemiological studies have generally reported that increased intake of antioxidants through diet or supplements, particularly vitamins E and C and β carotene, is associated with a lower risk of coronary heart disease.7–9 Other antioxidants, such as other …Keywords
This publication has 44 references indexed in Scilit:
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Homocysteine and coronary atherosclerosisJournal of the American College of Cardiology, 1996
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarctionJournal of the American College of Cardiology, 1994
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionNew England Journal of Medicine, 1991
- Differences in Coronary Heart Disease in Framingham, Honolulu and Puerto RicoJournal of Chronic Diseases, 1974
- RELATION OF VITAMIN C LEVELS TO MORTALITY IN A GERIATRIC HOSPITAL: A STUDY OF THE EFFECT OF VITAMIN C ADMINISTRATIONAge and Ageing, 1973